Document is current
Any future updates will be listed below
-
Authors
Lang, Alexander https://orcid.org/0000-0002-0584-3213
Schaefer, Edyta
Kupriyanova, Yuliya
Goletzke, Janina
Weber, Katharina S.
Buyken, Anette E.
Kahl, Sabine
Zaharia, Oana-Patricia
Herder, Christian
Schrauwen-Hinderling, Vera B.
Kuss, Oliver
Wagner, Robert
Roden, Michael
Schlesinger, Sabrina
,
Al-Hasani, Hadi
Frederik Belgardt, Bengt
J. Bönhof, Gidon
Geerling, Gerd
Icks, Andrea
Jandeleit-Dahm, Karin
Kotzka, Jörg
Lammert, Eckhard
Rathmann, Wolfgang
Szendroedi, Julia
Trenkamp, Sandra
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 30 April 2025
First Online: 10 May 2025
Declarations
:
: The study is performed according to the Declaration of Helsinki, was approved by the ethics board of the University of Düsseldorf (ref. 4508) and registered at Clinicaltrials.gov (NCT01055093). All participants provided their written informed consent.
: Not applicable.
: AEB is a member of the International Carbohydrate Quality Consortium (ICQC), a member of the Scientific committee of the transnational governance of the Nutri-Score system, a member of the Scientific Advisory Council for Agricultural Policy, Nutrition and Consumer Health Protection, Federal Ministry of Food and Agriculture Germany and a co-author of the popular cookbook “Nordisch abnehmen”. Her research is supported by grants from the German Research Foundation (BU 1807/3-2 & BU 1807/8-1), and the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” and from the ERA-NET Cofund HDHL INTIMIC (GA No. 727565 of the EU Horizon 2020 Research and Innovation Programme). The research of CH is supported by grants from the German Research Foundation (DFG) and the European Community (HORIZON-HLTH-2022-STAYHLTH-02-01: Panel A) to the INTERCEPT-T2D consortium. RW reports honoraria for lectures/presentations/speaker’s bureaus from Eli Lilly, Boehringer Ingelheim, NovoNordisk and Sanofi Aventis; travel support from NovoNordisk; honoraria for advisory boards from Eli Lilly and Akcea Therapeutics. MR received fees consulting, lecturing or serving on advisory boards from Astra Zeneca, Boehringer-Ingelheim, Echosens, Eli Lilly, Merck-MSD, Madrigal, Novo Nordisk, Madrigal and Target RWE and has performed investigator-initiated research with support from Boehringer-Ingelheim, Novo Nordisk and Nutricia/Danone to the DDZ. The research of MR is supported by grants from the German Research Foundation (DFG; RTG/GRK 2576), the European Community (HORIZON-HLTH-2022-STAYHLTH-02-01: Panel A) to the INTERCEPT-T2D consortium, BMG, MKW, BMBF and the Schmutzler-Stiftung.
